,4 Combinations of certain antibiotics and normal human serum at concentrations at which there was no killing by the agents when used alone were found to be bactericidal for Escherichia coli K-12 cells. This effect was observed with tetracycline, streptomycin (SM), trimethoprim, and ampicillin, but not with chloramphenicol or nalidixic acid. Synergy between SM and human serum was also observed against four of nine smooth strains of E. coli. A plasmid-bearing strain of E. coli K-12 was also killed by combinations of tetracycline or SM plus serum, even though the plasmid conferred resistance to tetracycline and SM. Evidence is presented that the synergy between antibiotics and serum is due to a complement-mediated effect on the bacterial cells that makes the cells more susceptible to the bactericidal effects of the antibiotics.
Measurement of the bactericidal effects of antibiotics in human serum as devised by Schlichter and MacLean (23) and modified by Jawetz (12) and many others has been performed for years, yet there have been only a few reports concerning the bactericidal effects of combinations of antibiotics and serum. It is well established that polymyxin B and serum, both of which have direct effects on the envelope of gram-negative cells, are synergistic (19, 27) or additive (26) when used in combination. However, there have been less consistent reports about other antibiotics. Chloramphenicol and serum have been reported to have an additive effect in killing Salmonella typhosa (28), whereas both chloramphenicol and tetracycline have been found to interfere (7, 8, 15, 30) with serum in killing of Escherichia coli. Ampicillin, though its action is directed against the bacterial cell wall, has been reported (27) to have no effect on serum bactericidal action. Kanamycin (27) had either no effect or an additive effect on serum bactericidal activity, depending on experimental conditions. The paucity of reports on the interactions between antibiotics and serum is, in part, the result of many tests being run with heat-inactivated serum, thereby precluding any possible combined activity. Furthermore, many tests do not include the controls of antibiotic alone and serum alone that are necessary for demonstration of synergy or interference with combinations. The lack of consistency in results is probably due to the large number of experimental variables which must be manipulated in experiments with combinations of antibiotics and serum.
As part of a program (20; A. M. Reynard (BES) and N-2-hydroxyethyl piperazine-N'-2-ethanesulfonic acid (HEPES) were purchased from ICN Pharmaceuticals, Inc. Penassay agar, Penassay broth, and MacConkey agar were purchased from Difco. Serum was collected from normal human volunteers, pooled, and kept at -70°C until used. The volunteers had taken no drugs for at least a week prior to collection of the serum.
Bacterial strains and plasmids. E. coli J6-2 (F-, pro, try, his, lac) was provided by J. T. Smith; E. coli J6-2R100 was from the laboratory collection. The plasmid, R100, provides resistance to TC, SM, CM, and sulfonamides. E. coli CSH-2 (F-, tip, lacZ, strA, thi) came from Cold Spring Harbor Laboratories. Smooth strains of E. coli were kindly provided by Betty Davis, Center for Disease Control, Atlanta, Ga, and Konrad Wicher, E. J. Meyer Memorial Hospital, Buffalo, N. Y.
Serum bactericidal assay for rough strains. The bactericidal assay used was similar to that of Taylor (25) except for the use of BES and HEPES to avoid the metal ion interaction and other difficulties encountered with tris(hydroxymethyl)aminomethane (Tris) buffer. Cells grown to exponential phase in Penassay broth were washed three times with 0.05 M NaCl and resuspended in 0.05 M NaCl to 9 x 101 cells per ml. The incubation mixture consisted of 0.5 ml of cell suspension; 0.25 ml of 0.1 M BES, pH 8.4, or 0.25 ml of 0.1 M HEPES, pH 7.4; 0.36 ml of 0.36 M NaCl; 0.25 ml of human serum diluted in 0.05 M NaCl; and water to a final volume of 2 ml. The use of broth was avoided because of the anti-complementary effects of broth components (15) . Additions to the incubation mixture were prepared in water, except where specified. No alteration of the antibody content of the serum was made. The reaction mixtures were incubated at 37°C for 2 h by which time bactericidal effects would be observed even with strains which had delayed susceptibility (24) . Samples taken at 0 and 2 h were diluted in Penassay broth and plated on Penassay agar for overnight incubation at 37°C. Percent survival was calculated as follows:
Colonies at 2 h Percent survival .
x 100
Colonies at 0 h Serum bactericidal assay for smooth strains. Since smooth strains are often more resistant than rough strains to the bactericidal effects of serum (22, 24), the incubation mixture was modified. The procedures were identical except for the incubation mixture as follows. Washed cells were resuspended in 0.05 M NaCl to 1.2 x 107 cells per ml. The reaction mixture consisted of 0.1 ml of cell suspension; 0.6 ml of undiluted human serum; and 0.1 ml of streptomycin in 0.1 M HEPES, pH 7.4 . When the serum was omitted, it was replaced by 0.6 ml of 0.18 M NaCl, and when the streptomycin was omitted, it was replaced by 0.1 ml of 0.1 M HEPES, pH 7.4. Complement hemolytic assays. Total hemolytic complement assay was essentially as described by Levine (14) . Briefly, washed sheep erythrocytes were sensitized with an optimal dilution of rabbit hemolytic antibody (amboceptor) and made to 5 x 107 cells per ml in isotonic Tris buffer, pH 7.4 . These cells were used to estimate the dilution of serum that contained 1 50% hemolytic complement unit for the human serum pool used in these experiments.
To evaluate the effect of tetracycline and streptomycin on total hemolytic complement activity, a dilution of serum that contained 1 50% hemolytic complement unit in 1 ml was added to 4 ml of Tris buffer followed by 1 ml of antibiotic solution. Both antibiotics were tested at 50 and 5 pg/ml. After antibiotic and serum were incubated for 30 min at room temperature, 1 ml of sensitized sheep erythrocytes was added, and the tubes were incubated for an additional 60 min at 37°C. At the end of incubation, the tubes were chilled to 4°C for 5 min and centrifuged to sediment ghosts and lysed cells. Each supernatant fluid was then measured for optical density at 413 nm. Controls were run similarly to correct for contribution to the optical density by the antibiotic. the cells were incubated with both antibiotic and serum. In all cases, the percent survival with antibiotic plus serum was different from antibiotic alone at the 0.05 level of significance as estimated by the two-tailed Student's t test. These results show that there is synergism between human serum and TC or SM in the killing of E. coli K-12. SM was more potent than TC in producing a bactericidal effect in the presence of serum. Serum complement, inactivated by heating at 560C for 30 min, had no bactericidal effect when combined with antibiotic at 50 ,ug/ml (data not shown), suggesting that the synergism between antibiotic and serum is complement dependent.
E. coli J6-2R100 is strain J6-2 bearing the plasmid R100, which confers resistance to both TC and SM. In the presence of serum, both TC and SM exhibited marked bactericidal effects on J6-2R100 (Fig. 1) . TC alone or SM alone had no bactericidal effect on J6-2R100. Thus, the antibiotic resistance of this strain can be overcome by exposing the cells to antibiotic in the presence of serum.
In experiments performed at pH 8.4, there was greater bactericidal activity than at 7.4. This was probably due to the increased activity of complement at pH 8 and various antibiotics are shown in Fig. 2 . There was no bactericidal effect of serum alone (see Fig. 1 ). When AM (50 ,ug/ml) was combined with serum, there was a marked increase in bactericidal activity. With PU and AM-D, there were slight increases in bactericidal activity, but only at concentrations that produced bactericidal activity of the agents alone. With AM (5 ,ug/ml), CM (50 ,ug/ml), and NA (50 ,ug/ml), there was no significant increase in bactericidal activity. It proved to be impossible to test RI in this system because of strong binding of the drug to serum. At concentrations of RI that were bactericidal when the drug was added alone, the addition of fresh serum at a final dilution of 1:320 prevented bactericidal activity.
For comparison, the minimum bactericidal concentration for each antibiotic was determined under the same conditions used for determination of potentiation by serum but with no added serum. For purposes of this study, the minimum bactericidal concentration was determined as the concentration of antibiotic which resulted in less than 30% survival of the original inoculum. The range of concentrations used was 25, 50, 100, 200, 500, and 1,000 yg/ml. The ,ig/ml or greater, and for CM, bactericidal activity could not be found even at 1,000 ug/ml. Bactericidal activity of serum plus antibiotic with E. coli CSH-2. E. coli CSH-2 is a high-level, SM-resistant mutant of E. coli K-12.
Resistance is due to a ribosomal alteration which produces resistance to SM at >1,000 jig/ml but no resistance to TC. Table 1 shows that SM at 50 ,ug/ml had no effect either alone or in combination with human serum on CSH-2. In contrast, other experiments (data not shown) had demonstrated that against the SM-susceptible strain, J6-2, SM alone at 50 ug/ml produced considerable killing and in combination with human serum gave less than 0.1% survival. With CSH-2 (Table 1) , there was no bactericidal activity of TC alone at 50 yg/ml, but the addition of human serum reduced survival to 6%. These results demonstrate that inhibition of protein synthesis by SM is necessary for the synergism of SM with human serum.
Effects of antibiotics on hemolytic complement activity. To test the possibility that SM and TC affect complement activity directly, thereby increasing the bactericidal activity of complement, antibiotic and a dilution of human serum containing 1 50% hemolytic complement unit were incubated for 30 min. Amboceptorsensitized sheep erythrocytes were then added and incubated for a further 60 win. Neither SM nor TC had any effect on complement-mediated lysis of sheep erythrocytes at either 2.5 or 50 itg/ml.
Time course of bactericidal effects of serum and SM. Although neither serum nor SM alone exhibited bactericidal activity at the con- Fig. 4 were designed torme whether human serum and the antibiotic acte i1i7sncert or sequentially. Thelag peioa previously observed (Fig. 3) suggested that one agent may act prior to the other to produce the augmented killing. In these experiments, the cells were preincubated with SM for 30 min prior to addition of the serum or were preincubated with serum for 30 min prior to addition of the SM. Fig. 3. ciently, there is no observable killing. Similarly, many antibiotics that are bactericidal at high concentrations are bacteriostatic but do not kill when diluted. We report here results of experiments which show that E. coli K-12 cells are efficiently killed by combinations of human serum and antibiotic at concentrations which, by themselves, produce no bactericidal activity. The participation of complement in this synergistic action is suggested by the lack of bactericidal effect when the same serum dilution is heated at 560C for 30 min. Furthermore, either Mg ethyleneglycol-bis (f,-aminoethyl ether)-N,N-tetraacetic acid or anti-C4 completely block killing by the combination of antibiotic and diluted serum (unpublished observations).
Bactericidal action of the combination de4ends on both the antibiotic concentration and erum dilution. Although 200 ug of TC per ml is /required for bactericidal activity when used alone, as little as 0.4 ,ug of TC per ml produced bactericidal activity in combination with serum. Similarly, significant bactericidal activity of serum alone was not observed at dilutions greater than 1:160, but in the presence of SM (2 jig/ml), killing occurred at dilutions as high as 1:800. The concentrations of TC or SM at which synergy is observed are thus in the range of therapeutic serum concentrations.
Smooth strains of E. coli are relatively resistant to the bactericidal activity of normal serum (22, 24) . Of nine smooth strains that were comhletely resistant to normal human serum (final gerum dilution of 3:4), four became susceptible to bactericidal activity when SM (5,ug/ml) was added, although SM alone at this concentration had almost no bactericidal effect.
Bactericidal activity of SM or TC plus serum was also measured with E. coli CSH-2, a highlevel, SM-resistant mutant of K-12. SM at 50
,ug/ml with or without serum exhibited no bactericidal effect on CSH-2, whereas TC plus sewas bactericidal. SM resistance by CSH-2 is due to a ribosomal alteration that prevents ibition of protein synthesis by SM at concenations less than 1,000 jg/ml, while not affecting he action of TC. These experiments demontrated that the bactericidal activity of SM plus rum depends on inhibition of protein synthesis by SM and eliminate the possibility that such activity is due to membrane damage by SM. They also suggest that SM does not increase the pactericidal activity of complement.
Other antibiotics such as AM and TM also exhibit bactericidal activity when used in combination with human serum. PU and AM-D have some bactericidal activity when combined with serum, but only at concentrations at which they show some bactericidal activity when used alone. A bactericidal effect could not be demonstrated for either CM or NA in combination with human serum at concentrations up to 50 ,Ag/ml.
The outer membrane of gram-negative organisms is a partial permeability barrier. Decad and Nikaido (3) showed that saccharides with molecular weights greater than approximately 600 are excluded. When the outer membrane is disrupted by ethylenediaminetetraacetic acid treatment, the penetration of various molecules, including some antibiotics, increases (13, 31) . It seems likely that serum, when used in combination with certain antibiotics, acts to disrupt the permeability barrier of the outer membrane, thereby increasing the intracellular concentration of antibiotic to a bactericidal level. This interpretation is supported by the demonstration that TM, TC, and SM were bactericidal alone at concentrations of 50, 200, and 50 ug/ml, respectively. CM was not potentiated by serum and was not bactericidal alone, even at 1,000 ,tg/ml, whereas NA was bactericidal only at 500 ,ug/ml. This is also consistent with the observation that the outer membrane is the site of initial attack by complement (5, 6, 32 ). An energydependent uptake in E. coli has been described for both TC (1, 4,9,21) and SM (2), presumably located at the plasma membrane. It is possible POTENTIATION OF ANTIBIOTIC ACTIVITY BY SERUM 825 that a complement-mediated reduction in the drug at its target site, the 30S ribosomal subunit. permeability barrier of the outer membrane re-Because the mechanisms of resistance are so sults in presentation of the antibiotics to the different, it seems unlikely that serum overplasma membrane in increased concentration. comes resistance by a direct effect on the resistThis interpretation is also supported by mea-ance mechanisms. A possible explanation, analsurement of the time course of killing. When SM ogous to that offered for the susceptible strains, and serum were added together, 15 to 30 min is that resistance is by-passed by a decrease in were required before killing began. When cells permeability due to complement action. The were preincubated with SM for 30 min and then observed synergy between serum and certain serum was added, there was also a 30-min delay antibiotics reported here is contrary to other after serum addition before killing. However, reports (7, 8, 30) , but variations in the test methwhen the cells were preincubated with serum ods may account for this. For example, Traub and then SM was added, killing began promptly. and Sherris (27) found no synergism and some These results suggest that the serum was affect-antagonism between AM or kanamycin and seing the cells in a way that made them more rum. susceptible to SM. If this is correct, then synerTheir tests differed from ours in that serum gism as demonstrated here represents an action dilutions of 1:2 and 1:10 in nutrient broth were of complement on the bacterial cell envelope used. Too little is known about the effects of which may be a preliminary to the killing event. broth to comment, but serum at those relatively
The possibility that TC and SM act by en-low dilutions produced considerable bactericidal hancing the effects of complement was tested by effect alone, perhaps making it more difficult to incubating antibiotic with serum and then mea-observe an effect of the antibiotic. In addition, suring the lytic power of the serum on sensitized serum proteins at these dilutions appeared to sheep erythrocytes. Neither TC nor SM had an bind the drugs. The use of extremely serumeffect on lysis of sheep erythrocytes by serum, susceptible rough strains in the experiments resuggesting that the antibiotic had no effect on ported here may have helped avoid some of classical complement activity. Furthermore, the these effects. Nevertheless, synergy was demalternative pathway of complement activity is onstrated with four of nine smooth strains at a affected by dilution such that at the high dilu-serum dilution of 3:4. Reports of interference tion of serum used here, alternative pathway with serum bactericidal action by TC (7, 8) are activity is essentially eliminated, and hence an less easy to evaluate, although bacterial strain effect of antibiotic to potentiate the alternative differences and serum dilutions may play a role. pathway directly seems unlikely. Pien and Vosti (18) have recently pointed out It is also possible that high dilutions of serum the marked variability of ways in which bacteproduce lesions in the cell envelope which ar ricidal tests are carried out in the clinical laborepaired rapidly enough to avoid cell death, bu ratory. More than 30 years after the first descripthat a repair is inhibited by TC and SM. The tion of a serum bactericidal test for antibiotic fact that CM is not synergistic with serum mili-effectiveness (23), it is obvious that there is still tates against this possibility. There are differ-the need to standardize such tests and perform ential effects of antibiotics on bacterial protein them in a way which will provide the best corsynthesis (10) , and it may be, though it appears relation with clinical effectiveness of the drug. unlikely, that TC and SM affect a repair mechanism and CM does not. 
